December 11th, 2017
jobs
homes

Menu
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chimerix, Inc. - Common Stock (NQ:CMRX)

8.540 UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Chimerix, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Top 3 Health Care Stocks That May Crash In Q2
 
Via Benzinga
Unusual volume stocks are being observed in Thursday's session.
Which stocks have an unusual volume on Thursday? 
Via Chartmill
This MongoDB Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
 
Via Benzinga
Here are the top movers in Wednesday's session.
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
These stocks are making the most noise in today's session.
Discover the most active stocks in Wednesday's session. Stay informed about the stocks that are generating the most trading volume! 
Via Chartmill
Demystifying Chimerix: Insights From 4 Analyst Reviews
 
Via Benzinga
A Glimpse Into The Expert Outlook On Chimerix Through 4 Analysts
 
Via Benzinga
CMRX Stock Earnings: Chimerix Misses EPS for Q1 2024
CMRX stock results show that Chimerix missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Which stocks are experiencing notable movement on Wednesday?
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements. 
Via Chartmill
Wednesday's session: gap up and gap down stocks
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
These stocks that are showing activity before the opening bell on Wednesday.
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
Preview: Chimerix's Earnings
 
Via Benzinga
Earnings Outlook For Chimerix
 
Via Benzinga
4 Analysts Have This to Say About Chimerix
 
Via Benzinga
Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline
Jazz Pharmaceuticals will add dordaviprone, a potential treatment for a rare brain tumor, to its growing oncology pipeline. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
S&P 500 Edges Lower; AutoZone Posts Downbeat Earnings
 
Via Benzinga
Topics Stocks
Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings
 
Via Benzinga
Dow Falls 150 Points; Oracle Posts Downbeat Results
 
Via Benzinga
Topics Stocks
Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday?
Chimerix plans to submit an NDA for dordaviprone to treat H3 K27M-mutant glioma, with potential U.S. FDA approval targeted for late 2025. 
Via Benzinga
Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
CMRX Stock Earnings: Chimerix Meets EPS, Beats Revenue for Q2 2024
CMRX stock results show that Chimerix met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones closed lower by around 388 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Overview Of Value Stocks In The Healthcare Sector
 
Via Benzinga
CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.
CMRX stock may seem like a high-risk, high-potential play, but it makes sense why the market has bid down this biotech. 
Via InvestorPlace
7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes
Although speculative trades are not for everyone, these millionaire-maker penny stocks could turn small bets into big returns. 
Via InvestorPlace
7 Small-Cap Stocks to Buy Before the Breakout
If you don’t mind the extreme risks involved, growth investors should target these ideas for best small cap stocks to buy. 
Via InvestorPlace
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look. 
Via InvestorPlace
7 Deeply Undervalued Growth Stocks to Buy in June
Investors may see significant rewards betting on these best undervalued growth stocks for June. 
Via InvestorPlace
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.